NCCM
CLVS

Nine Chapters Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Nine Chapters Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12,800
Closed -$530K – 1213
2014
Q2 		$530K Buy
+12,800
New +$659K 0.04% 525

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Nine Chapters Capital Management's CLVS Position: Q3 2014 in Review

Nine Chapters Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2014, closing a stake of 12,800 shares — an estimated $530K sold.

Nine Chapters Capital Management first reported a position in CLVS in Q2 2014 and held it in 1 quarter. The position peaked at $530K in Q2 2014. 138 funds tracked by Wall St. Rank hold CLVS as of Q3 2014.

  • Nine Chapters Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 12,800 Clovis Oncology, Inc. shares in Q3 2014, an estimated $530K.
  • Nine Chapters Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Clovis Oncology, Inc. position peaked at $530K in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2014.

Based on Nine Chapters Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.